Papers
5
Total Citations
114
H-Index
4
About
Dr. Alexandar Blazevski is a leading urologic surgeon and researcher specializing in the surgical management of prostate cancer, with a particular focus on minimally invasive and focal therapies. His work has been instrumental in advancing the field of robot-assisted surgery, both as a primary treatment and in salvage settings. Dr. Blazevski’s major contributions include pioneering the use of robot-assisted prostate-specific membrane antigen (PSMA)-radioguided surgery to improve the intraoperative detection of lymph node metastases, a technique demonstrated in his highly cited 2022 paper (51 citations). He has also been at the forefront of evaluating focal irreversible electroporation (IRE) as a treatment option, comparing its patient-reported quality-of-life outcomes against robot-assisted radical prostatectomy (RARP) in a pair-matched study (40 citations). Notably, Dr. Blazevski has established the feasibility and safety of salvage robot-assisted RARP following failed focal IRE, providing crucial data on oncological and functional outcomes for this challenging patient population. His work on unusual metastatic presentations, such as ureteric obstruction from prostate cancer, further highlights his comprehensive clinical expertise. With over 100 total citations, Dr. Blazevski’s research is shaping the future of personalized, nerve-sparing prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5Ureteric obstruction secondary to unusual metastasis of prostate cancer3 citations · 2020